BLUEBIRD STRATEGIES

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Income

$2.4M

Filings

207

Unique Clients

Active Period

2019–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$84,000	22	7
2025	$78,000	34	9
2024	$240,000	32	11
2023	$370,000	42	11
2022	$430,000	25	6
2021	$500,000	20	5
2020	$565,000	22	6
2019	$112,000	10	5

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
THERMO FISHER SCIENTIFIC INC.	$1,082,000	30	2019–2026
MYRIAD GENETICS INC	$590,000	21	2019–2024
PEAR THERAPEUTICS	$510,000	16	2019–2023
BOEHRINGER INGELHEIM USA CORPORATION	$60,000	5	2023–2024
OTSUKA AMERICA PHARMACEUTICAL, INC.	$40,000	4	2023
FAEGRE BAKER DANIELS CONSULTING (ON BEHALF OF GLOBAL DOWN SYNDROME FOUNDATION)	$32,000	4	2019–2020
MYOTONIC	$30,000	29	2019–2026
ATA ACTION	$30,000	4	2025
GLOBAL DOWN SYNDROME FOUNDATION	$5,000	27	2020–2026
LUMINOPIA, INC.	—	5	2023–2024
DIGITAL THERAPEUTICS ALLIANCE	—	3	2024–2025
MINDMAZE INC.	—	4	2023
CELLTRION USA, INC.	—	9	2024–2026
CLICK THERAPEUTICS, INC.	—	5	2023–2024
NCATS ALLIANCE	—	13	2024–2026
FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) SOCIETY	—	8	2025–2026
THE PEGGY LILLIS FOUNDATION	—	20	2022–2026

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	183
HOUSE OF REPRESENTATIVES	176
Health & Human Services, Dept of (HHS)	64
Natl Institutes of Health (NIH)	63
Defense, Dept of (DOD)	25
Food & Drug Administration (FDA)	9
Centers For Disease Control & Prevention (CDC)	6
Centers For Medicare and Medicaid Services (CMS)	2

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	104
Budget/Appropriations	Budget/Appropriations	92
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	68
Medicare/Medicaid	Medicare/Medicaid	65
Veterans	Veterans	15
Defense	Defense	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3491119th Congress

DeOndra Dixon INCLUDE Project Act of 2025

2026 · third_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: H.R. 3491

S. 1838119th Congress

DeOndra Dixon INCLUDE Project Act of 2026

2026 · third_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: S. 1838

H.R. 9061119th Congress

PREEMPT Act

2026 · third_quarter · Client: THERMO FISHER SCIENTIFIC INC.

Open original LDA filing ↗

Cited source text and reported amounts

Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation.

Client expense: — · Firm income: $21,000

Matched citations: H.R. 9061

H.R. 9061119th Congress

PREEMPT Act

2026 · second_quarter · Client: THERMO FISHER SCIENTIFIC INC.

Open original LDA filing ↗

Cited source text and reported amounts

Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation.

Client expense: — · Firm income: $21,000

Matched citations: H.R. 9061

Show 21 more cited filings

H.R. 3491119th Congress

DeOndra Dixon INCLUDE Project Act of 2025

2026 · second_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: H.R. 3491

S. 1838119th Congress

DeOndra Dixon INCLUDE Project Act of 2026

2026 · second_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: S. 1838

H.R. 3491119th Congress

DeOndra Dixon INCLUDE Project Act of 2025

2026 · first_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: H.R. 3491

S. 1838119th Congress

DeOndra Dixon INCLUDE Project Act of 2026

2026 · first_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: S. 1838

H.R. 3288119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · fourth_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (H.R.3288/S. 1702)

Client expense: — · Firm income: $10,000

Matched citations: H.R.3288

S. 1702119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · fourth_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (H.R.3288/S. 1702)

Client expense: — · Firm income: $10,000

Matched citations: S. 1702

H.R. 3491119th Congress

DeOndra Dixon INCLUDE Project Act of 2025

2025 · fourth_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: H.R. 3491

S. 1838119th Congress

DeOndra Dixon INCLUDE Project Act of 2026

2025 · fourth_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: S. 1838

H.R. 3288119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · fourth_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (H.R.3288/S. 1702)

Client expense: — · Firm income: $10,000

Matched citations: H.R.3288

S. 1702119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · fourth_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (H.R.3288/S. 1702)

Client expense: — · Firm income: $10,000

Matched citations: S. 1702

H.R. 3288119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · third_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (H.R.3288/S. 1702)

Client expense: — · Firm income: $10,000

Matched citations: H.R.3288

S. 1702119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · third_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (H.R.3288/S. 1702)

Client expense: — · Firm income: $10,000

Matched citations: S. 1702

H.R. 3491119th Congress

DeOndra Dixon INCLUDE Project Act of 2025

2025 · third_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: H.R. 3491

S. 1838119th Congress

DeOndra Dixon INCLUDE Project Act of 2026

2025 · third_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: S. 1838

H.R. 3288119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · third_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) Coverage/reimbursement DTx products FDA Prescription Drug Use-Related Software (PDURS)

Client expense: — · Firm income: —

Matched citations: H.R. 3288

H.R. 3288119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · third_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) Coverage/reimbursement DTx products FDA Prescription Drug Use-Related Software (PDURS)

Client expense: — · Firm income: —

Matched citations: H.R. 3288

S. 1702119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · third_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) Coverage/reimbursement DTx products FDA Prescription Drug Use-Related Software (PDURS)

Client expense: — · Firm income: —

Matched citations: S. 1702

S. 1702119th Congress

Access to Prescription Digital Therapeutics Act of 2025

2025 · third_quarter · Client: ATA ACTION

Open original LDA filing ↗

Cited source text and reported amounts

Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) Coverage/reimbursement DTx products FDA Prescription Drug Use-Related Software (PDURS)

Client expense: — · Firm income: —

Matched citations: S. 1702

H.R. 3491119th Congress

DeOndra Dixon INCLUDE Project Act of 2025

2025 · second_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: H.R. 3491

S. 1838119th Congress

DeOndra Dixon INCLUDE Project Act of 2026

2025 · second_quarter · Client: GLOBAL DOWN SYNDROME FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

DeOndra Dixon INCLUDE Project Act (H.R. 3491/S. 1838)

Client expense: — · Firm income: —

Matched citations: S. 1838

H.R. 9098118th Congress

Peggy Lillis Clostridioides difficile Inclusion Act

2024 · fourth_quarter · Client: THE PEGGY LILLIS FOUNDATION

Open original LDA filing ↗

Cited source text and reported amounts

Peggy Lillis C. difficile Inclusion Act (H.R. 9098) CDC Infection Disease Public Health & Epidemiology Funding. Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization. Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PASTEUR Act.

Client expense: — · Firm income: —

Matched citations: H.R. 9098

Source: Senate LDA

BLUEBIRD STRATEGIES — Lobbying Disclosure | Poliscope